This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
American neurology lost one of its most prominent and vocal spokesmen for bioethics when Dr. Ronald E. Cranford died of metastatic renal carcinoma on May 31, 2006, at age 65 years. Ron was much in the national news throughout 2005 as an expert witness in the sensationalized and tragic case of Teresa Schiavo, but this public role culminated his long history of involvement and advocacy in other precedent-setting medicolegal cases. More than any other neurologist, he helped to catalyze the recognition that it could be ethically acceptable for physicians to discontinue life-sustaining therapy on neurologic patients with impaired consciousness.
Ron was born in Peoria, Illinois, where he developed a lifelong love of golf. He attended the University of Illinois on an Evans Scholarship awarded to promising golf caddies, and the University of Illinois College of Medicine from which he was graduated in 1965. After internship at Presbyterian-St. Lukes Hospital, he served in the US Air …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg